THC/THCA-dominant cannabis extracts showed the most protection against amyloid-beta neurotoxicity in cell cultures, though not by blocking amyloid aggregation.
Alzheimer's researchers, neuropharmacologists, and those following cannabinoid-based drug development.
THC/THCA-dominant extracts were most neuroprotective, but not by blocking amyloid aggregation
What the researchers found
Five proprietary cannabis extracts were tested against amyloid-beta toxicity in PC12 cells. THC/THCA-dominant extracts provided the most significant neuroprotection, persisting after heating. None protected against lipid peroxidation. Neuroprotection did not correlate with amyloid aggregation inhibition.
Why it matters
Most Alzheimer's drug development has focused on clearing amyloid plaques with limited success. If cannabis extracts protect neurons through alternative mechanisms, this could open new therapeutic avenues.
The numbers in context
Five proprietary cannabis extracts tested. THC/THCA-predominant extracts showed the most significant neuroprotection. Only one non-heated extract (BC-401) modestly inhibited amyloid aggregation.
How the study worked
In vitro study using PC12 cells exposed to amyloid-beta-1-42 peptide. Cell viability by MTT assay. Five cannabis extracts tested heated and non-heated. Amyloid aggregation visualized by electron and fluorescence microscopy.
What this study cannot tell us
In vitro study in PC12 cells (a cancer cell line). No in vivo validation. Proprietary extracts limit reproducibility.
How to read the evidence
In vitro study in a cancer cell line with no animal or human validation.
When this study was published
Published in 2024.
The bigger picture
The disconnect between neuroprotection and amyloid aggregation inhibition suggests cannabinoids may protect brain cells through anti-inflammatory or other pathways, aligning with growing skepticism about the amyloid-only hypothesis.
Questions still open
- Through what mechanism do THC/THCA extracts protect neurons if not by blocking amyloid aggregation?
- Would these neuroprotective effects translate to animal models of Alzheimer's?
Common questions
Can cannabis prevent Alzheimer's?
Which type of cannabis extract was most protective?
Read the original research
Medicinal cannabis extracts are neuroprotective against Aβ1-42-mediated toxicity in vitro.
Basic & clinical pharmacology & toxicology, 135(5), 575-592
Citation
Marsh, Dylan T; Shibuta, Mayu; Kato, Ryuji; Smid, Scott D. (2024). Medicinal cannabis extracts are neuroprotective against Aβ1-42-mediated toxicity in vitro.. Basic & clinical pharmacology & toxicology, 135(5), 575-592. https://doi.org/10.1111/bcpt.14078
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk